Trial ID 18020 | Maryland Oncology Hematology Trial ID 18020 – Maryland Oncology Hematology

Trial ID 18020

Trial Information - Phase I/IIa

A Phase 1/2a Study of BMS-986253 in Combination with Nivolumab in Advanced Cancers

Protocol ID: CA027002

Sponsor: BRISTOL-MYERS SQUIBB

Status: OPEN TO ENROLLMENT

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Melanoma

Investigator

Wallmark MD, John

Status

OPEN TO ENROLLMENT

Sponsor

BRISTOL-MYERS SQUIBB

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology